|
Volumn 24, Issue 6 SUPPL. 19, 1997, Pages
|
Chemotherapy for relapsed head and neck cancer: Paclitaxel, cisplatin, and 5-fluorouracil in chemotherapy-naive patients. A dose-finding study
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
PACLITAXEL;
RECOMBINANT COLONY STIMULATING FACTOR;
ADULT;
AGED;
ARTICLE;
ASTHENIA;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
DOSE CALCULATION;
DRUG SAFETY;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
MUCOSA INFLAMMATION;
MYALGIA;
NEUTROPENIA;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
TOXICITY TESTING;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
FEMALE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HEMOGLOBINOMETRY;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEUTROPHILS;
PACLITAXEL;
PLATELET COUNT;
|
EID: 0031473628
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (19)
|
References (21)
|